Anterix CLO exercises options, withholds shares

Anterix Inc. Chief Legal Officer and Corporate Secretary Gena L. Ashe reported option-related transactions in company stock.

Accepted by SEC EDGAR 03/04/2026 - 05:49 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Anterix Inc. Chief Legal Officer and Corporate Secretary Gena L. Ashe reported option-related transactions in company stock. On March 3, 2026, Ashe exercised stock options for 12,427 shares, converting them into an equal number of Anterix common shares at an exercise price of $27.83 per share.

On the same date, 12,427 common shares were disposed of in a transaction coded as a tax-withholding event, using shares to satisfy the exercise price or tax obligations. Following these transactions, Ashe directly owned 13,366 shares of Anterix common stock.

Insider Trade Summary

12,427 shares exercised/converted

Exercise 3 txns

Insider Ashe Gena L

Role Chief Legal Officer & Corp Sec

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	12,427	$0.00	$0.00
Exercise	Common Stock	12,427	$27.83	$346K
Exercise Price or Tax Liability	Common Stock	12,427	$36.18	$450K

Holdings After Transaction: Stock Option (Right to Buy) — 24,848 contracts (Direct); Common Stock — 13,366 shares (Direct)

Holdings Before and After: Stock Option (Right to Buy), 37,275 to 24,848 contracts (Direct); Common Stock, 13,366 to 13,366 shares (Direct)

Footnotes (2)

1. F1. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $35.92 to $36.61 The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
2. F2. The option shares are fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Anterix (ATEX) report for Gena L. Ashe?

Anterix reported that Chief Legal Officer Gena L. Ashe exercised stock options for 12,427 shares and disposed of 12,427 common shares in a tax-withholding transaction, all dated March 3, 2026, as part of option exercise activity.

How many Anterix (ATEX) shares did Gena L. Ashe acquire through option exercise?

Gena L. Ashe exercised stock options covering 12,427 shares of Anterix common stock. These options were fully vested and converted into an equal number of common shares at an exercise price of $27.83 per share on March 3, 2026.

What does the Form 4 tax-withholding transaction mean for Anterix (ATEX)?

The Form 4 shows 12,427 Anterix common shares disposed of in a tax-withholding transaction. This means shares were used to pay the option exercise price or related tax liabilities, rather than representing an ordinary open-market sale by the insider.

How many Anterix (ATEX) shares does Gena L. Ashe hold after these transactions?

After the reported March 3, 2026 transactions, Gena L. Ashe directly held 13,366 shares of Anterix common stock. This figure reflects her direct ownership following the option exercise and related tax-withholding disposition reported on Form 4.

What roles does Gena L. Ashe hold at Anterix (ATEX) in this Form 4 filing?

In this Form 4, Gena L. Ashe is identified as an officer of Anterix, serving as Chief Legal Officer and Corporate Secretary. Her reported transactions involve stock options and common shares associated with her role and related equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ashe Gena L

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NJ 07424

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer & Corp Sec

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		M		12,427	A	$27.83	25,793	D
Common Stock	03/03/2026		F		12,427	D	$36.18(1)	13,366	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$27.83	03/03/2026		M			12,427	(2)	01/16/2035	Common Stock	12,427	$0	24,848	D

Explanation of Responses:

1. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $35.92 to $36.61 The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

2. The option shares are fully vested.

Remarks:

	/s/ Gena L. Ashe	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.